BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23303849)

  • 1. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
    Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
    Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease.
    Babiloni C; Carducci F; Lizio R; Vecchio F; Baglieri A; Bernardini S; Cavedo E; Bozzao A; Buttinelli C; Esposito F; Giubilei F; Guizzaro A; Marino S; Montella P; Quattrocchi CC; Redolfi A; Soricelli A; Tedeschi G; Ferri R; Rossi-Fedele G; Ursini F; Scrascia F; Vernieri F; Pedersen TJ; Hardemark HG; Rossini PM; Frisoni GB
    Hum Brain Mapp; 2013 Jun; 34(6):1427-46. PubMed ID: 22331654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
    Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
    Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
    Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
    Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.
    Jack CR; Petersen RC; Xu Y; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Tangalos EG; Kokmen E
    Neurology; 2000 Aug; 55(4):484-89. PubMed ID: 10953178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophy rates accelerate in amnestic mild cognitive impairment.
    Jack CR; Weigand SD; Shiung MM; Przybelski SA; O'Brien PC; Gunter JL; Knopman DS; Boeve BF; Smith GE; Petersen RC
    Neurology; 2008 May; 70(19 Pt 2):1740-52. PubMed ID: 18032747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.
    Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC;
    PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.
    Evans MC; Barnes J; Nielsen C; Kim LG; Clegg SL; Blair M; Leung KK; Douiri A; Boyes RG; Ourselin S; Fox NC;
    Eur Radiol; 2010 Mar; 20(3):674-82. PubMed ID: 19760240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
    Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
    Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.
    Macdonald KE; Bartlett JW; Leung KK; Ourselin S; Barnes J;
    Alzheimer Dis Assoc Disord; 2013; 27(2):168-73. PubMed ID: 22760170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional signature of conversion of patients with mild cognitive impairment.
    Delli Pizzi S; Punzi M; Sensi SL;
    Neurobiol Aging; 2019 Feb; 74():21-37. PubMed ID: 30408719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.